Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial-Reference-Cited by-同舟云学术

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

Published:2010-06-25 Issue:8 Volume:19 Page:1217-1225
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Celio Luigi, ,Frustaci Sergio,Denaro Angela,Buonadonna Angela,Ardizzoia Antonio,Piazza Elena,Fabi Alessandra,Capobianco Alba Maria,Isa Luciano,Cavanna Luigi,Bertolini Alessandro,Bichisao Ettore,Bajetta Emilio

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://www.springerlink.com/index/pdf/10.1007/s00520-010-0941-7

Reference22 articles.

1. Sharma R, Tobin P, Clarke SJ (2005) Management of chemotherapy-induced nausea, vomiting, oral mucositis, diarrhoea. Lancet Oncol 6:93–102. doi: 10.1016/S1470-2045(05)01735-3

2. Grunberg SM (2007) Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol 18:233–240

3. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482–2494

4. Hesketh PJ, Kris MG, Grunberg SM et al (1997) Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 15:103–109

5. Roila F, Hesketh PJ, Herrstedt J et al (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17:20–28. doi: 10.1093/annonc/mdj078

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

2. Low dose of dexamethasone combined with netupitant and palonosetron in preventing nausea and vomiting in breast cancer patients induced by anthracycline drugs;Clinical and Translational Oncology;2024-07-13

3. Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study);JCO Global Oncology;2024-02

4. Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis;Supportive Care in Cancer;2023-12-26

5. Possibilities of prevention of nausea during cytostatic therapy: literature review and clinical cases;Meditsinskiy sovet = Medical Council;2023-07-27